Viral Gastroenteritis Latest Advances

AI-Based Exhaled VOC Panels as Gut Microbiota-Derived Biomarkers for IBD Screening.

Journal: ACS sensors

Published: December 16, 2025

Sepsis and mucositis-related biomarkers in adult hematologic patients with febrile neutropenia.

Journal: Leukemia & lymphoma

Published: December 16, 2025

Apparent expansion of virulent Vibrio parahaemolyticus in humans and sea otters.

Journal: Virulence

Published: December 16, 2025

Recipients' native bacteria determine the outcome of FMT treatment in inflammatory bowel disease.

Journal: Gut microbes

Published: December 16, 2025

Diagnostic value of fecal calprotectin detection in infants with milk protein-allergic enteritis

Journal: Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences

Published: December 16, 2025

Ornithine lipids from Akkermansia muciniphila are dynamically modulated in colitis and shape macrophage inflammatory responses.

Journal: Gut microbes

Published: December 16, 2025

Timing of intravenous infliximab administration affects inflammatory bowel disease outcomes.

Journal: Chronobiology international

Published: December 15, 2025

Compartment Syndrome Secondary to Phlegmasia Cerulea Dolens in a Patient With Crohn's Disease.

Journal: The American journal of case reports

Published: December 15, 2025

Recommendations for the diagnosis and management of eosinophilic esophagitis in adults and children in Canada: a Delphi consensus project.

Journal: Journal of the Canadian Association of Gastroenterology

Published: December 15, 2025

Risk of serious infections in patients with inflammatory bowel disease treated with biologic and small molecule therapies: A nationwide cohort study.

Journal: Journal of Crohn's & colitis

Published: December 15, 2025

Temporal trends in 30-day and 90-day hospital readmission rates among individuals with inflammatory bowel diseases in Ontario, Canada: a population-based study.

Journal: Journal of the Canadian Association of Gastroenterology

Published: December 15, 2025

Models of outpatient care delivery in inflammatory bowel disease: a scoping review.

Journal: Journal of the Canadian Association of Gastroenterology

Published: December 15, 2025

Filters

AI-Based Exhaled VOC Panels as Gut Microbiota-Derived Biomarkers for IBD Screening.

AI-Based Exhaled VOC Panels as Gut Microbiota-Derived Biomarkers for IBD Screening.

Sepsis and mucositis-related biomarkers in adult hematologic patients with febrile neutropenia.

Sepsis and mucositis-related biomarkers in adult hematologic patients with febrile neutropenia.

Apparent expansion of virulent Vibrio parahaemolyticus in humans and sea otters.

Apparent expansion of virulent Vibrio parahaemolyticus in humans and sea otters.

Recipients' native bacteria determine the outcome of FMT treatment in inflammatory bowel disease.

Recipients' native bacteria determine the outcome of FMT treatment in inflammatory bowel disease.

Diagnostic value of fecal calprotectin detection in infants with milk protein-allergic enteritis

Diagnostic value of fecal calprotectin detection in infants with milk protein-allergic enteritis

Ornithine lipids from Akkermansia muciniphila are dynamically modulated in colitis and shape macrophage inflammatory responses.

Ornithine lipids from Akkermansia muciniphila are dynamically modulated in colitis and shape macrophage inflammatory responses.

Timing of intravenous infliximab administration affects inflammatory bowel disease outcomes.

Timing of intravenous infliximab administration affects inflammatory bowel disease outcomes.

Compartment Syndrome Secondary to Phlegmasia Cerulea Dolens in a Patient With Crohn's Disease.

Compartment Syndrome Secondary to Phlegmasia Cerulea Dolens in a Patient With Crohn's Disease.

Recommendations for the diagnosis and management of eosinophilic esophagitis in adults and children in Canada: a Delphi consensus project.

Recommendations for the diagnosis and management of eosinophilic esophagitis in adults and children in Canada: a Delphi consensus project.

Risk of serious infections in patients with inflammatory bowel disease treated with biologic and small molecule therapies: A nationwide cohort study.

Risk of serious infections in patients with inflammatory bowel disease treated with biologic and small molecule therapies: A nationwide cohort study.

Temporal trends in 30-day and 90-day hospital readmission rates among individuals with inflammatory bowel diseases in Ontario, Canada: a population-based study.

Temporal trends in 30-day and 90-day hospital readmission rates among individuals with inflammatory bowel diseases in Ontario, Canada: a population-based study.

Models of outpatient care delivery in inflammatory bowel disease: a scoping review.

Models of outpatient care delivery in inflammatory bowel disease: a scoping review.